Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

IRIS- DESyne X2 in the IRIS-DES Registry

NCT: NCT03588481 · RECRUITING

NCT IDNCT03588481
StatusRECRUITING
Start Date2018-11-28
Completion2031-12-31
SponsorSeung-Jung Park (OTHER)
First posted
Last updated

Brief Summary

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Frequently Asked Questions

What is IRIS- DESyne X2 in the IRIS-DES Registry?

IRIS- DESyne X2 in the IRIS-DES Registry is a clinical trial registered under NCT03588481. Current status: RECRUITING.

What is the status of NCT03588481?

The current status of NCT03588481 (IRIS- DESyne X2 in the IRIS-DES Registry) is: RECRUITING.

When did IRIS- DESyne X2 in the IRIS-DES Registry start?

IRIS- DESyne X2 in the IRIS-DES Registry started on 2018-11-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑